Search - tctmd.com

Displaying 801 - 820 of 1304

Sort: Relevancy | Date

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

Presentation TCT 2013

TCT-2. Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from th...

Presenter: Tracy Wang

October 29, 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presentation TCT 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presenter: Michael Rinaldi

October 29, 2013

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presentation TCT 2013

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Dmitriy Feldman

October 28, 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

October 23, 2013

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presentation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presenter: Christoph Varenhorst

October 18, 2013

News Daily News

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

October 11, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

October 11, 2013

News Daily News

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

October 11, 2013

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

October 04, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

October 04, 2013

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

October 04, 2013

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

October 04, 2013

News Daily News

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

October 04, 2013

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Presentation

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Presenter: A. Majeed

October 03, 2013

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Presentation

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Presenter: M. Kenaan

October 02, 2013

Meta-analysis of Randomized Trials on Risk of MI from the Use of Oral Direct Thrombin Inhibitors

Presentation

Meta-analysis of Randomized Trials on Risk of MI from the Use of Oral Direct Thrombin Inhibitors

Presenter: Ramin Artang

October 01, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

September 20, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.